Hydroxyurea: MedlinePlus Drug Information
Hydroxyurea is in a class of medications called antimetabolites. Hydroxyurea treats cancer by slowing or stopping the growth of cancer cells in your body. Hydroxyurea treats sickle cell anemia by helping to prevent formation of sickle-shaped red blood cells.
Hydroxyurea: Uses, Interactions, Mechanism of Action
Hydroxyurea is an antimetabolite used to treat sickle cell anemia crisis, resistant chronic myeloid leukemia, and Locally advanced squamous cell carcinomas of the head and neck (excluding the lip).
羟基脲 - 维基百科，自由的百科全书
羟基脲 （INN： Hydroxycarbamide，又名 Hydroxyurea，商品名包括 Hydrea 和 Droxia）是一种 化疗 及 抗逆转录病毒药物，被用于治疗 慢性粒细胞白血病 、 骨髓增生性疾病 和 镰刀型细胞贫血症 等疾病。 羟基脲的其中一种普遍接受的机理是它能够通过清除酪氨酰 自由基 来抑制 核糖核苷酸二磷酸还原酶，从而阻碍 脱氧核糖核苷酸 的合成。 [2][3] 在镰刀型细胞贫血症的治疗中，羟基脲能够增加 胎儿血红蛋白 的浓度。 这点的具体作用机理仍不清楚，但有研究认为羟基脲能够增加 …
Hydroxyurea Uses, Side Effects & Warnings - Drugs.com
2023年8月9日 · Hydroxyurea is used to treat chronic myeloid leukemia, ovarian cancer, and certain types of skin cancer (squamous cell cancer of the head and neck). Hydroxyurea is also used to reduce pain episodes and the need for blood transfusions in people with sickle cell anemia. Hydroxyurea will not cure sickle cell anemia.
Hydroxyurea (oral route) - Mayo Clinic
Hydroxyurea is used to treat cancer of the white blood cells called chronic myeloid leukemia (CML). It may also be given together with radiation treatment for head and neck cancer (advanced squamous cell cancer).
Hydroxycarbamide - Wikipedia
Hydroxycarbamide, also known as hydroxyurea, is an antimetabolite medication used in sickle-cell disease, essential thrombocythemia, chronic myelogenous leukemia, polycythemia vera, and cervical cancer.
Hydroxyurea: Side Effects, Dosage, Uses, and More - Healthline
2021年3月12日 · Hydroxyurea oral capsule (Hydrea, Droxia) is used to treat certain cancers and sickle cell disease. Learn about side effects, warnings, dosage, and more.
Hydroxyurea: Side Effects, Uses, Dosage, Interactions, Warnings - RxList
Hydroxyurea is an antineoplastic (anti-cancer) agent used to treat melanoma, resistant chronic myelocytic leukemia, and recurrent, metastatic, or inoperable carcinoma of the ovary and primary squamous cell (epidermoid) carcinomas of the head and neck.
Hydroxyurea Monograph for Professionals - Drugs.com
2024年6月10日 · Antineoplastic agent; exhibits beneficial effects against sickle cell anemia; exhibits antiviral activity. Treatment of resistant chronic myelogenous leukemia (CML).
Hydroxyurea | CH4N2O2 | CID 3657 - PubChem
Hydroxyurea is a member of the class of ureas that is urea in which one of the hydrogens is replaced by a hydroxy group. An antineoplastic used in the treatment of chronic myeloid leukaemia as well as for sickle-cell disease.